GC Biopharma Corp. (KRX:006280)
South Korea
· Delayed Price · Currency is KRW 139,200
-900 (-0.64%)
Last updated: Apr 29, 2026, 2:00 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.60 trillion as of April 28, 2026. Its market cap has increased by 11.10% in one year.
Market Cap
1.60T
Enterprise Value
2.71T
Revenue
1.99T
Ranking
n/a
PE Ratio
n/a
Stock Price
139,200.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.60T, an increase of 5,397.46%. That is a compound annual growth rate of 13.95%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewoong Pharmaceutical | 1,721.34B |
| Chong Kun Dang Pharmaceutical | 1,158.18B |
| DongKook Pharmaceutical | 1,141.30B |
| Celltrion Pharm | 2,560.02B |
| Hanall Biopharma | 2,630.45B |
| Daewoong | 942.53B |
| Ildong Pharmaceutical | 885.38B |
| Boryung | 843.12B |